[1]
W. Zarzycka, “RIMEGEPANT AS A NOVEL THERAPEUTIC OPTION FOR MIGRAINE: A SYSTEMATIC REVIEW OF SAFETY AND TOLERABILITY”, IJITSS, vol. 5, no. 1(49), Mar. 2026, doi: 10.31435/ijitss.1(49).2026.5290.